203 related articles for article (PubMed ID: 29122547)
1. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
2. Statin use and survival in patients with gastric cancer in two independent population-based cohorts.
Spence AD; Busby J; Hughes CM; Johnston BT; Coleman HG; Cardwell CR
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):460-470. PubMed ID: 30456916
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
García Rodríguez LA; Soriano-Gabarró M; Vora P; Cea Soriano L
Int J Cancer; 2020 Nov; 147(9):2394-2404. PubMed ID: 32329063
[TBL] [Abstract][Full Text] [Related]
4. Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
Liu P; McMenamin ÚC; Spence AD; Johnston BT; Coleman HG; Cardwell CR
BMC Cancer; 2019 Oct; 19(1):1017. PubMed ID: 31664951
[TBL] [Abstract][Full Text] [Related]
5. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
Lin JL; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Huang CM
BMC Cancer; 2020 Jul; 20(1):638. PubMed ID: 32646396
[TBL] [Abstract][Full Text] [Related]
6. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
[TBL] [Abstract][Full Text] [Related]
7. Exposure to oral bisphosphonates and risk of esophageal cancer.
Cardwell CR; Abnet CC; Cantwell MM; Murray LJ
JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457
[TBL] [Abstract][Full Text] [Related]
8. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
Ayyagari S; Tan MC; Liu Y; El-Serag HB; Thrift AP
Dig Dis Sci; 2020 Sep; 65(9):2691-2699. PubMed ID: 31802383
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ
Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656
[TBL] [Abstract][Full Text] [Related]
10. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.
Macfarlane TV; Murchie P; Watson MC
Cancer Epidemiol; 2015 Dec; 39(6):1015-22. PubMed ID: 26590503
[TBL] [Abstract][Full Text] [Related]
12. Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study.
Alexandre L; Clark AB; Bhutta HY; Chan SS; Lewis MP; Hart AR
Gastroenterology; 2016 Apr; 150(4):854-65.e1; quiz e16-7. PubMed ID: 26775632
[TBL] [Abstract][Full Text] [Related]
13. Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort.
Cardwell CR; Kunzmann AT; Cantwell MM; Hughes C; Baron JA; Powe DG; Murray LJ
Gastroenterology; 2014 Mar; 146(3):700-708.e2. PubMed ID: 24239563
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and esophageal and gastric cancer.
Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y
Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604
[TBL] [Abstract][Full Text] [Related]
15. Low-dose aspirin use and endometrial cancer mortality-a Danish nationwide cohort study.
Sperling CD; Verdoodt F; Aalborg GL; Dehlendorff C; Friis S; Kjaer SK
Int J Epidemiol; 2020 Feb; 49(1):330-337. PubMed ID: 31845990
[TBL] [Abstract][Full Text] [Related]
16. Statin use and breast cancer survival: a nationwide cohort study in Scotland.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
BMC Cancer; 2016 Aug; 16():600. PubMed ID: 27491389
[TBL] [Abstract][Full Text] [Related]
17. Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer.
Kim MH; Chang J; Kim WJ; Banerjee S; Park SM
Am J Gastroenterol; 2018 Jun; 113(6):845-854. PubMed ID: 29855546
[TBL] [Abstract][Full Text] [Related]
18. Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.
Cardwell CR; Flahavan EM; Hughes CM; Coleman HG; O'Sullivan JM; Powe DG; Murray LJ
Cancer Causes Control; 2014 Jan; 25(1):33-43. PubMed ID: 24310109
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
Busby J; McMenamin Ú; Spence A; Johnston BT; Hughes C; Cardwell CR
Aliment Pharmacol Ther; 2018 Jan; 47(2):279-288. PubMed ID: 29105106
[TBL] [Abstract][Full Text] [Related]
20. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy.
Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M
Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
